Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:6.2.1.1 (
ACS
)
78,556
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Wnt proteins are secreted morphogens that play critical roles in embryonic development and tissue remodeling in adult organisms. Aberrant Wnt signaling contributes to diseases such as cancer. Wnts are modified by an unusual
O
-fatty acylation event (
O
-linked palmitoleoylation of a conserved serine) that is required for binding to Frizzled receptors.
O
-Palmitoleoylation of Wnts is introduced by the porcupine (PORCN) acyltransferase and removed by the serine hydrolase
NOTUM
. PORCN inhibitors are under development for oncology, while
NOTUM
inhibitors have potential for treating degenerative diseases. Here, we describe the use of activity-based protein profiling (ABPP) to discover and advance a class of
N
-hydroxyhydantoin (NHH) carbamates that potently and selectively inhibit
NOTUM
. An optimized NHH carbamate inhibitor, ABC99, preserves Wnt-mediated cell signaling in the presence of
NOTUM
and was also converted into an ABPP probe for visualizing
NOTUM
in native biological systems.
ACS
Med Chem Lett 2018 Jun 14
PMID:Selective Irreversible Inhibitors of the Wnt-Deacylating Enzyme NOTUM Developed by Activity-Based Protein Profiling. 2993 83